This contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $3,573.45 award is for the delivery of 68 mg NEXPLANON implants, a contraceptive device, to support the recurring medical supply needs of military healthcare facilities.
DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA that enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated its ability to provide a diverse array of specialized medications and medical supplies to the Department of Defense.
Generated 3/9/25, 12:51 AM